TargetMol

Fidaxomicin

Product Code:
 
TAR-T6194
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6194-5mg5mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6194-10mg10mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6194-25mg25mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6194-1mL1 mL * 10 mM (in DMSO)£120.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6194-50mg50mg£130.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6194-100mg100mg£172.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6194-200mg200mg£220.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Fidaxomicin is a semisynthetic macrolide antibiotic used to treat Clostridium difficile-associated diarrhea in adults. Fidaxomicin has minimal systemic absorption and has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent, acute liver injury.
CAS:
873857-62-6
Formula:
C52H74Cl2O18
Molecular Weight:
1058.05
Pathway:
Microbiology/Virology; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Apoptosis
Purity:
0.9982
SMILES:
[H][C@@]1(O[C@@H]2[C@@H](CC)C=C(C)[C@@H](O)CC=CC=C(CO[C@@H]3O[C@H](C)[C@@H](OC(=O)c4c(O)c(Cl)c(O)c(Cl)c4CC)[C@H](O)[C@@H]3OC)C(=O)O[C@@]([H])(CC=C(/C)C=C2/C)[C@@H](C)O)OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O
Target:
Apoptosis; DNA/RNA Synthesis; Antibacterial; Antibiotic

References

Sun Q, Liao X, Wang C, et al. In vitro activity of fidaxomicin against nontuberculosis mycobacteria. Journal of Medical Microbiology. 2022, 71(6): 001549 Venugopal AA, et al. Clin Infect Dis, 2012, 54(4), 568-574.